Examiner Ashwin Mehta

Appears inactive Last observed office action: December 2010 (183 months ago).

Examiner Ashwin Mehta appears to be very easy relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 74.3%, they average 1.30 office actions per granted patent, and their rejection profile leans toward §103 and elevated §112 usage.

Difficulty vs AU Very Easy

Difficulty vs Group Very Easy

Difficulty vs TC Very Easy

Difficulty vs USPTO Very Easy

Average OA / Grant 1.30

Export

Word PDF

Create account to export.

Examiner Details

Observed Examiner Years: 3 years (2008-2010)
Tech Center: 1600 - Biotechnology and Organic
Group: 1630 - Stem Cells and Nucleic Acid Related Therapy

Metrics

Applications Evaluated: 113
Granted Applications: 84
Non-Granted Applications: 29
Avg OA / Grant: 1.30
Last OA Observed: December 2010 (183 months ago)
Art Units Seen: 1638
Work Groups Seen: 1630 - Stem Cells and Nucleic Acid Related Therapy

Context Comparison

Scope	Examiners	Lifetime Grant Ratio	Avg OA / Grant
This Examiner	1	74.3%	1.30
Art Unit	15	37.6%	1.45
Group	243	38.4%	2.18
Tech Center	1,349	39.5%	2.02
USPTO	16,116	54.8%	1.98

Grant Timeline

Shaded region marks the last two observed years, where grant outcomes may lag due to recency.

Year	Applications	Granted	Grant Rate
No observed data before 2008; examiner may not yet have been active in the available dataset.
2008	23	13	56.5%
2009	46	35	76.1%
2010	44	36	81.8%
No observed data after 2010; examiner may have gone inactive or moved out of examining work.

84 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA #	Office Actions	§ 101 Percentage	§ 102 Percentage	§ 103 Percentage	§ 112 Percentage
1	113	0.0%	14.2%	26.5%	35.4%
2	34	2.9%	11.8%	47.1%	26.5%
3	7	0.0%	0.0%	85.7%	14.3%

§ 101 Yearly Trend

0.0%

2008

1.6%

2009

0.0%

2010

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.